OTC · Medical - Devices

Cannabix Technologies Inc. (BLOZF) Stock

$0.38 -0.03% OTC: BLOZF Healthcare

Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer technologies for employers, law enforcement, workplaces, and laboratories in the United States. It offers Cannabix Marijuana Breath Test (MBT) for Tetrahydrocannabinol (THC) detection and quantification; Cannabix breath collection unit and breath cartridge for human breath sample collection, storage, and transportation.

Valuation

MetricValue
Price$0.38
Market Cap$46.58M
P/E Ratio-9.93
P/B Ratio40.89
P/S Ratio409.89
EPS (TTM)$-0.04
52-Week High$0.68
52-Week Low$0.32
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-302.99%
ROA-343.07%
ROCE-399.83%
Gross Margin-89.35%
Operating Margin-1028.23%
Net Margin0.00%
Debt/Equity0.03
Current Ratio6.44

Annual Financials (USD)

Metric20212022202320242025
Revenue$7.0M$0$0$0$0
Operating Profit$-9.0M$-3.0M$-2.0M$-3.0M$-4.0M
Net Profit$-9.0M$-3.0M$-2.0M$-3.0M$-5.0M
EPS$-0.09$-0.03$-0.02$-0.03$-0.04
Op Margin-138.5%————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$10.0M$9.0M$7.0M$5.0M$3.0M
Total Liabilities$0$0$0$0$0
Cash$10.0M$8.0M$6.0M$4.0M$2.0M
Borrowings$0$0$0$0$0

Latest News

Cannabix Technologies Develops Breath-Based Testing Panel for Recent Drug Use Detection MT Newswires · Jul 8, 2026 Cannabix Technologies and Omega Laboratories Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection GlobeNewswire · Jul 8, 2026 Omega Laboratories and Cannabix Technologies Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection PR Newswire · Jul 8, 2026 Cannabix Technologies Announces Detection of Cocaine and Benzoylecgonine in Human Breath GlobeNewswire · Jul 6, 2026 Cannabix Expands Breath Testing Potential with Breakthrough Detection of Methamphetamine and Amphetamine InvestorsHub · Jul 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-2.0M$-2.0M$-2.0M$-2.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$2.0M$-2.0M$-2.0M$-2.0M$-2.0M
Free Cash Flow$-2.0M$-2.0M$-2.0M$-2.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.17
EV / EBITDA-10.57
FCF Yield-2.89%
Quick Ratio5.99
Interest Coverage-453.66
Return 1Y-15.56%
Return 3Y89.05%
Return 5Y—

Ownership

Insiders Held11.67%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Hantz Financial Services, Inc. 3892026-03-31
Leo H. Evart, Inc.302026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AIRDFRocket Doctor AI Inc. $0.45 -1.16% -2.54 $43.12M 0.00%
CRRVFCVR Medical Corp. $0.00 — 0.00 $1072 0.00%
CXXIFC21 Investments Inc. $0.21 -3.53% -9.40 $24.33M 0.00%
ELIXFElixxer Ltd. $0.03 +0.00% -0.14 $23.35M 0.00%
INNMFAmplia Therapeutics Limited $0.11 +0.00% -8.38 $56.46M 0.00%

About Cannabix Technologies Inc.

Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer technologies for employers, law enforcement, workplaces, and laboratories in the United States. It offers Cannabix Marijuana Breath Test (MBT) for Tetrahydrocannabinol (THC) detection and quantification; Cannabix breath collection unit and breath cartridge for human breath sample collection, storage, and transportation. The company also provides BreathLogix alcohol breathalyzer, an autonomous alcohol screening system that enables screening of employees, contractors, and visitors in mining, construction, and oil and gas industries; and BreathLogix Connect (BLC), a cloud platform that is designed for streamlining data. It has a strategic partnership and development agreement with Omega Laboratories Inc. for the development and commercialization of the MBT technology. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.

Cannabix Technologies Inc. is headquartered in CA.

Cannabix Technologies Inc. (BLOZF) stock trades at $0.38 with a market capitalization of $46.58M. The stock is valued at a price-to-earnings (P/E) ratio of -9.93, price-to-book of 40.89, price-to-sales of 409.89. Over the past 52 weeks the stock has ranged between $0.32 and $0.68, and currently trades 44.1% below its 52-week high.

On profitability, Cannabix Technologies Inc. generates a return on equity (ROE) of -302.99%, return on capital employed of -399.83%, an operating margin of -1028.23%, a net profit margin of 0.00%.

Official website: www.cannabixtechnologies.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides